impact factor, citescore
logo
 

Letters to the Editor

 

Efficacy of anifrolumab as a first-line therapy for the treatment of thrombocytopenia in systemic lupus erythematosus: a case report


1, 2, 3, 4, 5, 6

 

  1. Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. francesca.bottazzi01@gmail.com
  2. Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  3. Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  4. Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  5. Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  6. Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

CER18377
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 40153335 [PubMed]

Received: 25/11/2024
Accepted : 23/12/2024
In Press: 20/03/2025

Rheumatology Article